Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 40 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $33.60 million which beat the analyst consensus estimate of $32.24 million by 4.22 percent. This is a 51.93 percent increase over sales of $22.12 million the same period last year.
Axogen Q2 EPS $(0.09) Beats $(0.13) Estimate, Sales $33.60M Beat $32.24M Estimate
Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 40 percent increase over losses of $(0.15) per share from the same
